LeMaitre Vascular, Inc. (LMAT)

Add to research

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance
Add to research
View more

Current Price

as of Mar 14, 2025

$81.91

P/E Ratio

42.37

Market Cap

$1.85B

Mar 21, 2024Apr 25, 2024May 30, 2024Jul 3, 2024Aug 5, 2024Sep 6, 2024Oct 10, 2024Nov 13, 2024Dec 19, 2024Jan 28, 2025Mar 14, 2025$0.00$10.00$20.00
  • DHCA
Description
Add to research
View more

LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company focuses on the design, marketing, sales, service, and technical support of medical devices and implants for the treatment of peripheral vascular disease. Its products include balloon catheters, carotid shunts, biologic patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, vascular grafts, and powered phlebectomy. The company was founded by George D. LeMaitre on November 28, 1983 and is headquartered in Burlington, MA.

Metrics
Add to research
View more

Overview

  • HQBurlington, MA
  • SectorHealth Technology
  • IndustryMedical Specialties
  • TickerLMAT
  • Price$81.91+3.92%

Trading Information

  • Market cap$1.85B
  • Float91.13%
  • Average Daily Volume (1m)267,288
  • Average Daily Volume (3m)203,352
  • EPS$1.96

Company

  • Revenue$219.86M
  • Rev growth (1yr)13.63%
  • Net income$44.04M
  • Gross margin66.00%
  • EBITDA margin28.20%
  • EBITDA$62.00M
  • EV$1.98B
  • EV/Revenue9.03
  • P/E42.37
  • P/S8.49
  • P/B5.48
  • Debt/Equity55.05
Documents
Add to research
View more